TIFFANY REPLOGLE: Open Payments
NPI 1871569467 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 90 payments from 17 companies in 2025. Trend: 2023 $823 · 2024 $1,298 · 2025 $1,441
Food & beverage: $1,398Education: $43
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $303 |
| Novartis Pharmaceuticals Corporation | 15 | $197 |
| GENZYME CORPORATION | 9 | $169 |
| Janssen Biotech, Inc. | 11 | $152 |
| ABBVIE INC. | 9 | $144 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Amgen Inc. | 3 | $73 |
| Incyte Corporation | 3 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, Otezla, OPZELURA, EBGLYSS.
Industry payments across PA — which companies pay providers there.
